IL-10 -1082 SNP and IL-10 in primary CNS and vitreoretinal lymphomas

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 250, Issue 10, 2012, Pages 1541-1548

  Ramkumar, Hema L ^a,b   Shen, De Fen ^a   Tuo, Jingsheng ^a   Braziel, Rita M ^c   Coupland, Sarah E ^d   Smith, Justine R ^c   Chan, Chi Chao ^a  

^a NATIONAL EYE INSTITUTE   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Interleukin 10; PDCD4 (program cell death 4); Primary CNS lymphoma; Primary vitreoretinal lymphoma; Single nucleotide polymorphism

Indexed keywords

GENOMIC DNA; INTERLEUKIN 10; INTERLEUKIN 6; MEMBRANE PROTEIN; MESSENGER RNA; PARAFFIN; PROGRAMMED CELL DEATH 4; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE; GENE DOSAGE; GENE EXPRESSION; GENE FREQUENCY; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERLEUKIN 10 GENE; LYMPHOMA CELL; MALE; MICRODISSECTION; MOLECULAR TYPING; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; PRIMARY VITREORETINAL LYMPHOMA; PRIORITY JOURNAL; PROGRAMMED CELL DEATH 4 GENE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS REGULATORY PROTEINS; BRAIN NEOPLASMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EYE NEOPLASMS; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; INTERLEUKIN-10; LYMPHOMA, B-CELL; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RETINAL NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA-BINDING PROTEINS; VITREOUS BODY; YOUNG ADULT;

EID: 84867742952     PISSN: 0721832X     EISSN: 1435702X     Source Type: Journal    
DOI: 10.1007/s00417-012-2037-1     Document Type: Article

References (54)

1. O'Neill BP (2004) Epidemiology of primary CNS lymphoma. In: Lymphoma of the nervous system. Butterworth-Heinemann, Boston, pp 1-207
2. Pulido JS, Vierkant RA, Olson JE, Abrey L, Schiff D, O'Neill BP (2009) Racial differences in primary central nervous system lymphoma incidence and survival rates. Neuro Oncol 11:318-322
3. Olson JE, Janney CA, Rao RD, Cerhan JR, Kurtin PJ, Schiff D, Kaplan RS, O'Neill BP (2002) The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma: a surveillance, epidemiology, and end results analysis. Cancer 95:1504-1510
4. Schabet M (1999) Epidemiology of primary CNS lymphoma. J Neurooncol 43:199-201
5. Banchereau J, Schmitt D (1995) Dendritic cells in fundamental and clinical immunology. In: Advances in experimental medicine and biology. Plenum Press, New York, pp 1-572, Volume 2
6. Kleihues PC, WK (2000) Pathology and genetics of tumours of the nervous system. In: World Health Organization classification of tumors. Lyon, France, pp 1-314
7. Chan CC, Gonzales JA (2007) Primary intraocular lymphoma. World Scientific Publishing Co Pte Ltd., Hackensack, NJ, pp 1-200
8. Chan CC, Rubenstein JL, Coupland SE, Davis JL, Harbour JW, Johnston PB, Cassoux N, Touitou V, Smith JR, Batchelor TT, Pulido JS (2011) Primary vitreoretinal lymphoma: a report from an international primary central nervous system lymphoma collaborative group symposium. Oncologist 16:1589-1599
9. Coupland SE, Damato B (2008) Understanding intraocular lymphoma. Clin Experiment Ophthalmol 36:564-578
10. Fast stats: Statistics stratified by cancer site: National Cancer Institute. Surveillance, Epidemiology, and End Results. Accessed May 8, 2011
11. Faia LJ, Chan CC (2009) Primary intraocular lymphoma. Arch Pathol Lab Med 133:1228-1232
12. Kuppers R (2005) Mechanisms of B-cell lymphoma pathogenesis. Nat Rev Cancer 5:251-262
13. Lenz G, Wright GW, Emre NC, Kohlhammer H, Dave SS, Davis RE, Carty S, Lam LT, Shaffer AL, Xiao W, Powell J, Rosenwald A, Ott G, Muller-Hermelink HK, Gascoyne RD, Connors JM, Campo E, Jaffe ES, Delabie J, Smeland EB, Rimsza LM, Fisher RI, Weisenburger DD, Chan WC, Staudt LM (2008) Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways. Proc Natl Acad Sci USA 105:13520-13525
14. Cassoux N, Giron A, Bodaghi B, Tran TH, Baudet S, Davy F, Chan CC, Lehoang P, Merle-Beral H (2007) Il-10 measurement in aqueous humor for screening patients with suspicion of primary intraocular lymphoma. Invest Ophthalmol Vis Sci 48:3253-3259
15. Chan CC, Whitcup SM, Solomon D, Nussenblatt RB (1995) Interleukin-10 in the vitreous of patients with primary intraocular lymphoma. Am J Ophthalmol 120:671-673
16. Sen HN, Chan CC, Byrnes G, Fariss RN, Nussenblatt RB, Buggage RR (2008) Intravitreal methotrexate resistance in a patient with primary intraocular lymphoma. Ocul Immunol Inflamm 16:29-33
17. Salmaggi A, Eoli M, Corsini E, Gelati M, Frigerio S, Silvani A, Boiardi A (2000) Cerebrospinal fluid interleukin-10 levels in primary central nervous system lymphoma: a possible marker of response to treatment? Ann Neurol 47:137-138
18. Lech-Maranda E, Bienvenu J, Michallet AS, Houot R, Robak T, Coiffier B, Salles G (2006) Elevated IL-10 plasma levels correlate with poor prognosis in diffuse large B-cell lymphoma. Eur Cytokine Netw 17:60-66
19. Banchereau J, Briere F, Liu YJ, Rousset F (1994) Molecular control of B lymphocyte growth and differentiation. Stem Cells 12:278-288
20. Rousset F, Garcia E, Defrance T, Peronne C, Vezzio N, Hsu DH, Kastelein R, Moore KW, Banchereau J (1992) Interleukin-10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci USA 89:1890-1893
21. Petersson M, Charo J, Salazar-Onfray F, Noffz G, Mohaupt M, Qin Z, Klein G, Blankenstein T, Kiessling R (1998) Constitutive IL-10 production accounts for the high NK sensitivity, low MHC class I expression, and poor transporter associated with antigen processing (TAP)-1/2 function in the prototype NK target YAC-1. J Immunol 161:2099-2105
22. Lan Q, Zheng T, Rothman N, Zhang Y, Wang SS, Shen M, Berndt SI, Zahm SH, Holford TR, Leaderer B, Yeager M, Welch R, Boyle P, Zhang B, Zou K, Zhu Y, Chanock S (2006) Cytokine polymorphisms in the Th1/Th2 pathway and susceptibility to non- Hodgkin lymphoma. Blood 107:4101-4108
23. Lech-Maranda E, Baseggio L, Bienvenu J, Charlot C, Berger F, Rigal D, Warzocha K, Coiffier B, Salles G (2004) Interleukin-10 gene promoter polymorphisms influence the clinical outcome of diffuse large B-cell lymphoma. Blood 103:3529-3534
24. Purdue MP, Lan Q, Kricker A, Grulich AE, Vajdic CM, Turner J, Whitby D, Chanock S, Rothman N, Armstrong BK (2007) Polymorphisms in immune function genes and risk of non-Hodgkin lymphoma: findings from the New South Wales non-Hodgkin Lymphoma Study. Carcinogenesis 28:704-712
25. Rothman N, Skibola CF, Wang SS, Morgan G, Lan Q, Smith MT, Spinelli JJ, Willett E, De Sanjose S, Cocco P, Berndt SI, Brennan P, Brooks-Wilson A, Wacholder S, Becker N, Hartge P, Zheng T, Roman E, Holly EA, Boffetta P, Armstrong B, Cozen W, Linet M, Bosch FX, Ennas MG, Holford TR, Gallagher RP, Rollinson S, Bracci PM, Cerhan JR, Whitby D, Moore PS, Leaderer B, Lai A, Spink C, Davis S, Bosch R, Scarpa A, Zhang Y, Severson RK, Yeager M, Chanock S, Nieters A (2006) Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. Lancet Oncol 7:27-38
26. Cunningham LM, Chapman C, Dunstan R, Bell MC, Joske DJ (2003) Polymorphisms in the interleukin 10 gene promoter are associated with susceptibility to aggressive non-Hodgkin's lymphoma. Leuk Lymphoma 44:251-255
27. Domingo-Domenech E, Benavente Y, Gonzalez-Barca E,Montalban C, Guma J, Bosch R, Wang SS, Lan Q, Whitby D, Fernandez de Sevilla A, Rothman N, de Sanjose S (2007) Impact of interleukin-10 polymorphisms (-1082 and -3575) on the survival of patients with lymphoid neoplasms. Haematologica 92:1475-1481
28. Hohaus S, Giachelia M, Massini G, Vannata B, Criscuolo M, Martini M, D'Alo F, Voso MT, Larocca LM, Leone G (2009) Clinical significance of interleukin-10 gene polymorphisms and plasma levels in Hodgkin lymphoma. Leuk Res 33:1352-1356
29. Reuss E, Fimmers R, Kruger A, Becker C, Rittner C, Hohler T (2002) Differential regulation of interleukin-10 production by genetic and environmental factors-a twin study. Genes Immun 3:407-413
30. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV (1997) An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 24:1-8
31. Gibson AW, Edberg JC, Wu J, Westendorp RG, Huizinga TW, Kimberly RP (2001) Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus. J Immunol 166:3915-3922
32. Kurreeman FA, Schonkeren JJ, Heijmans BT, Toes RE, Huizinga TW (2004) Transcription of the IL10 gene reveals allele-specific regulation at the mRNA level. Hum Mol Genet 13:1755-1762
33. Jansen AP, Camalier CE, Stark C, Colburn NH (2004) Characterization of programmed cell death 4 in multiple human cancers reveals a novel enhancer of drug sensitivity. Mol Cancer Ther 3:103-110
34. Lankat-Buttgereit B, Goke R (2003) Programmed cell death protein 4 (pdcd4): A novel target for antineoplastic therapy? Biol Cell 95:515-519
35. Hilliard A, Hilliard B, Zheng SJ, Sun H, Miwa T, SongW, Goke R, Chen YH (2006) Translational regulation of autoimmune inflammation and lymphoma genesis by programmed cell death 4. J Immunol 177:8095-8102
36. Sheedy FJ, Palsson-McDermott E, Hennessy EJ, Martin C, O'Leary JJ, Ruan Q, Johnson DS, Chen Y, O'Neill LA (2010) Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nat Immunol 11:141-147
37. Gonzales JA, Chan CC (2007) Biopsy techniques and yields in diagnosing primary intraocular lymphoma. Int Ophthalmol 27:241-250
38. Shen DF, Zhuang Z, LeHoang P, Boni R, Zheng S, Nussenblatt RB, Chan CC (1998) Utility of microdissection and polymerase chain reaction for the detection of immunoglobulin gene rearrangement and translocation in primary intraocular lymphoma. Ophthalmology 105:1664-1669
39. Chan CC (2003) Molecular pathology of primary intraocular lymphoma. Trans Am Ophthalmol Soc 101:275-292
40. Levy-Clarke GA, Byrnes GA, Buggage RR, Shen DF, Filie AC, Caruso RC, Nussenblatt RB, Chan CC (2001) Primary intraocular lymphoma diagnosed by fine needle aspiration biopsy of a subretinal lesion. Retina 21:281-284
41. Lech-Maranda E, Baseggio L, Charlot C, Rigal D, Berger F, Jamroziak K, Warzocha K, Coiffier B, Salles G (2007) Genetic polymorphisms in the proximal IL-10 promoter and susceptibility to non-Hodgkin lymphoma. Leuk Lymphoma 48:2235-2238
42. Vuoristo MS (2007) The polymorphisms of interleukin-10 gene influence the prognosis of patients with advanced melanoma. Cancer Genet Cytogenet 176:54-57
43. Eskdale J, McNicholl J, Wordsworth P, Jonas B, Huizinga T, Field M, Gallagher G (1998) Interleukin-10 microsatellite polymorphisms and IL-10 locus alleles in rheumatoid arthritis susceptibility. Lancet 352:1282-1283
44. Coupland SE, Chan CC, Smith J (2009) Pathophysiology of retinal lymphoma. Ocul Immunol Inflamm 17:227-237
45. Wang Y, Shen D, Wang VM, Sen HN, Chan CC (2011) Molecular biomarkers for the diagnosis of primary vitreoretinal lymphoma. Int J Mol Sci 12:5684-5697
46. Kawamura H, Yasuda N, Kakinoki M, Sawada T, Sawada O, Ohji M (2009) Interleukin-10 and interleukin-6 in aqueous humor during treatment of vitreoretinal lymphoma with intravitreally injected methotrexate. Ophthalmic Res 42:172-174
47. Sou R, Ohguro N, Maeda T, Saishin Y, Tano Y (2008) Treatment of primary intraocular lymphoma with intravitreal methotrexate. Jpn J Ophthalmol 52:167-174
48. Coupland SE, Hummel M, Stein H, Willerding G, Jahnke K, Stoltenburg-Didinger G (2005) Demonstration of identical clonal derivation in a case of "oculocerebral" lymphoma. Br J Ophthalmol 89:238-239
49. Blay JY, Burdin N, Rousset F, Lenoir G, Biron P, Philip T, Banchereau J, Favrot MC (1993) Serum interleukin-10 in non- Hodgkin's lymphoma: a prognostic factor. Blood 82:2169-2174
50. Rajagopal R, Harbour JW (2011) Diagnostic testing and treatment choices in primary vitreoretinal lymphoma. Retina 31:435-440
51. Whitcup SM, Stark-Vancs V, Wittes RE, Solomon D, Podgor MJ, Nussenblatt RB, Chan CC (1997) Association of interleukin 10 in the vitreous and cerebrospinal fluid and primary central nervous system lymphoma. Arch Ophthalmol 115:1157-1160
52. Allgayer H (2010) Pdcd4, a colon cancer prognostic that is regulated by a microRNA. Crit Rev Oncol Hematol 73:185-191
53. Lee CG, Kang KH, So JS, Kwon HK, Son JS, Song MK, Sahoo A, Yi HJ, Hwang KC, Matsuyama T, Yui K, Im SH (2009) A distal cisregulatory element, CNS-9, controls NFAT1 and IRF4-mediated IL- 10 gene activation in T helper cells. Mol Immunol 46:613-621
54. Liopeta K, Boubali S, Virgilio L, Thyphronitis G, Mavrothalassitis G, Dimitracopoulos G, Paliogianni F (2009) cAMP regulates IL-10 production by normal human T lymphocytes at multiple levels: a potential role for MEF2. Mol Immunol 46:345-354